Eugene, OR, United States of America

Shervin Esfandiari

USPTO Granted Patents = 11 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1997-2017

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Shervin Esfandiari: Innovator in Pharmaceutical Chemistry

Introduction

Shervin Esfandiari is a prominent inventor based in Eugene, OR (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work focuses on developing innovative compounds that address various medical conditions.

Latest Patents

One of his latest patents involves benzimidazole derivatives as selective blockers of persistent sodium current. This invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof. The patent outlines pharmaceutical compositions comprising this compound and methods for treating diseases or conditions mediated by elevated persistent sodium current, such as ocular disorders, multiple sclerosis, seizure disorders, and chronic pain.

Career Highlights

Shervin Esfandiari is currently associated with Allergan, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments that improve patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Lloyd Jay Dolby and Michael E Garst, contributing to a dynamic research environment that fosters innovation.

Conclusion

Shervin Esfandiari's contributions to pharmaceutical chemistry and his innovative patents highlight his commitment to improving healthcare solutions. His work continues to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…